Raymond James Maintains Outperform on ICU Medical, Raises Price Target to $158
Portfolio Pulse from Benzinga Newsdesk
Raymond James analyst Jayson Bedford maintains an Outperform rating on ICU Medical (NASDAQ:ICUI) and raises the price target from $135 to $158.
August 08, 2024 | 4:49 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Raymond James analyst Jayson Bedford maintains an Outperform rating on ICU Medical and raises the price target from $135 to $158.
The raised price target and maintained Outperform rating from a reputable analyst at Raymond James is likely to positively impact ICU Medical's stock price in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100